Furthermore, a significant reduction in intratumoral CD4+Foxp3+ regulatory T cells (Tregs) was observed, suggesting that bardoxolone methyl disrupts immunosuppressive regulatory networks within the tumor microenvironment. Here, CD4 is linked to neoplasm.